Milone, Maria Rita <br/><br/>
Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.  [electronic resource] 

 -  Oncotarget  Mar 2015 
 - 5324-41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.2694  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blotting, Western<br/>Bone Density Conservation Agents--pharmacology<br/>Cell Movement<br/>Cell Proliferation<br/>Diphosphonates--pharmacology<br/>Drug Resistance, Neoplasm<br/>Electrophoresis, Gel, Two-Dimensional<br/>Gene Ontology<br/>Gene Regulatory Networks<br/>Humans<br/>Imidazoles--pharmacology<br/>Male<br/>Neoplasm Invasiveness<br/>Prostatic Neoplasms--drug therapy<br/>Proteomics--methods<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction--drug effects<br/>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization<br/>Tumor Cells, Cultured<br/>Zoledronic Acid